PropertyValue
?:abstract
  • Objectives There was an outbreak of pediatric multisystem inflammation syndrome (PMIS) was observed in multiple countries recently, and this syndrome was suspected to be associated with SARS-CoV-2 infection. At present, there is still no standardized diagnostic criteria and treatment regimen for PMIS, while the etiology and pathogenesis still remain unclear. Methods We performed a systematic review on PubMed and Embase from the time of inception to June 24th 2020 in order to find relevant cases. Results There are seven studies included, and 80% of patients suffered persistent fever and 90% appeared gastrointestinal symptoms. IgG antibody against SARS-CoV-2 was positive on 81% of patients, while 37% of the patients were nucleic acid positive. C-reactive protein, IL-6 and PCT were elevated and intravenous immunoglobulin was a routine treatment for PMIS. There were more than half of patients required inotropic supports and mechanical ventilation were applied to 33% of patients. The median length of hospital stay was 10.66 days and 74% had admitted to accept intensive care. Conclusions Our study documented three common types of PMIS clinical presentation: persistent fever and gastrointestinal symptoms, shocked with heart dysfunction and Kawasaki disease-like syndrome. PMIS patients proved with a marked inflammatory state were possibly associated with SARS-CoV-2 infection.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.ijid.2020.11.145
?:doi
?:journal
  • Int_J_Infect_Dis
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/6ba90a8e4929706455c7b1ec40448b8baeb737db.json
?:pmcid
?:pmid
?:pmid
  • 33202218.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis
?:type
?:year
  • 2020-11-14

Metadata

Anon_0  
expand all